Material Event (Form 8-K)

Item 8.01 Other Events.

On January 12, 2026, Cingulate Inc. (the "Company") increased the maximum aggregate offering price of the shares of the Company's common stock, par value $0.0001 per share (the "Common Stock") issuable under the At The Market Offering Agreement (the "Sales Agreement") with H.C. Wainwright & Co., LLC, dated January 3, 2023, from $23,536,658 to $31,936,658 and filed a prospectus supplement (the "Current Prospectus Supplement") under the Sales Agreement for an aggregate of $8,840,000. Prior to the date hereof, the Company sold shares of common stock having an aggregate sales price of $15,145,503.74 under the Sales Agreement. A copy of the legal opinion as to the legality of the $8,840,000 of shares of Common Stock issuable under the Sales Agreement and covered by the Current Prospectus Supplement is filed as Exhibit 5.1 attached hereto.